Phase 2 Readout~quarter
Phase 2 Readout: al001
- Company
- Alzamend Neuro, Inc. (ALZN)
- Drug
- al001
- Indication
- bipolar disorder type 1
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.